Quantum BioPharma Ltd.
QNTM
$3.24
-$0.20-5.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.16M | -31.16M | -26.18M | -28.51M | -27.02M |
| Total Depreciation and Amortization | 530.50K | 543.50K | 545.80K | 529.20K | 504.70K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Other Non-Cash Items | 15.11M | 26.57M | 15.41M | 10.51M | 8.82M |
| Change in Net Operating Assets | 4.04M | -1.60M | 1.99M | 8.70M | 7.19M |
| Cash from Operations | -5.49M | -5.64M | -8.24M | -8.77M | -10.51M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.50M | -3.50M | -1.95M | -1.06M | -4.93M |
| Cash from Investing | -3.50M | -3.50M | -1.95M | -1.06M | -4.93M |
| Total Debt Issued | 3.02M | 4.98M | 5.36M | 6.36M | 5.78M |
| Total Debt Repaid | -1.81M | -2.61M | -1.61M | -882.40K | -876.80K |
| Issuance of Common Stock | 8.21M | 5.88M | 529.70K | 1.68M | 8.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.72M | 1.72M | 1.82M | -- | -- |
| Cash from Financing | 11.13M | 9.96M | 6.10M | 7.15M | 13.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.15M | 823.70K | -4.09M | -2.67M | -1.81M |